X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs GSK PHARMA - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA GSK PHARMA ABBOTT INDIA/
GSK PHARMA
 
P/E (TTM) x 32.3 59.9 54.0% View Chart
P/BV x 8.1 11.7 68.8% View Chart
Dividend Yield % 0.8 2.1 39.6%  

Financials

 ABBOTT INDIA   GSK PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
GSK PHARMA
Mar-16
ABBOTT INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs6,0153,850 156.2%   
Low Rs3,7072,966 125.0%   
Sales per share (Unadj.) Rs1,236.9332.3 372.2%  
Earnings per share (Unadj.) Rs122.244.3 275.8%  
Cash flow per share (Unadj.) Rs129.047.2 273.1%  
Dividends per share (Unadj.) Rs35.0050.00 70.0%  
Dividend yield (eoy) %0.71.5 49.1%  
Book value per share (Unadj.) Rs521.2202.7 257.1%  
Shares outstanding (eoy) m21.2584.70 25.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.910.3 38.3%   
Avg P/E ratio x39.876.9 51.7%  
P/CF ratio (eoy) x37.772.2 52.2%  
Price / Book Value ratio x9.316.8 55.5%  
Dividend payout %28.6112.9 25.4%   
Avg Mkt Cap Rs m103,296288,643 35.8%   
No. of employees `0003.04.6 64.1%   
Total wages/salary Rs m3,3704,434 76.0%   
Avg. sales/employee Rs Th8,891.86,104.5 145.7%   
Avg. wages/employee Rs Th1,140.0961.6 118.6%   
Avg. net profit/employee Rs Th878.3813.7 107.9%   
INCOME DATA
Net Sales Rs m26,28428,148 93.4%  
Other income Rs m5041,218 41.4%   
Total revenues Rs m26,78929,366 91.2%   
Gross profit Rs m3,6654,774 76.8%  
Depreciation Rs m144248 58.2%   
Interest Rs m80-   
Profit before tax Rs m4,0175,744 69.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m1,4212,018 70.4%   
Profit after tax Rs m2,5963,752 69.2%  
Gross profit margin %13.917.0 82.2%  
Effective tax rate %35.435.1 100.7%   
Net profit margin %9.913.3 74.1%  
BALANCE SHEET DATA
Current assets Rs m14,44621,462 67.3%   
Current liabilities Rs m4,72510,536 44.8%   
Net working cap to sales %37.038.8 95.3%  
Current ratio x3.12.0 150.1%  
Inventory Days Days5168 76.0%  
Debtors Days Days2016 119.1%  
Net fixed assets Rs m1,1134,717 23.6%   
Share capital Rs m213847 25.1%   
"Free" reserves Rs m10,80816,308 66.3%   
Net worth Rs m11,07617,171 64.5%   
Long term debt Rs m016 0.0%   
Total assets Rs m16,24130,620 53.0%  
Interest coverage x497.0NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.9 176.1%   
Return on assets %16.012.3 130.9%  
Return on equity %23.421.9 107.3%  
Return on capital %36.333.6 108.3%  
Exports to sales %0.60 4,326.5%   
Imports to sales %12.615.1 84.0%   
Exports (fob) Rs m1624 4,040.0%   
Imports (cif) Rs m3,3224,237 78.4%   
Fx inflow Rs m268519 51.6%   
Fx outflow Rs m3,9278,320 47.2%   
Net fx Rs m-3,659-7,801 46.9%   
CASH FLOW
From Operations Rs m2,5141,386 181.5%  
From Investments Rs m-8005,010 -16.0%  
From Financial Activity Rs m-803-6,383 12.6%  
Net Cashflow Rs m91212 7,728.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 50.7 147.9%  
Indian inst/Mut Fund % 7.9 10.2 77.5%  
FIIs % 0.1 23.8 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 15.4 111.0%  
Shareholders   18,270 102,036 17.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   AUROBINDO PHARMA  MERCK LTD  SANOFI INDIA  J.B.CHEMICALS  ORCHID PHARMA LTD  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 21, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS